Compared with the use of other migraine medications, use of erenumab did not increase cardiovascular or cerebrovascular risks.

Company to host conference call and webcast today at 8:00 a.m. ET--MIAMI, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Veru Inc.

USA A 46-year-old man was transferred from an outside hospital for evaluation of acute renal failure and non-ST-segment elevation myocardial infarction. During his initial presentation at the outside ...

The following is a summary of "Sex differences in outcomes in patients with acute myocardial infarction," published in the ...

For patients with myocardial infarction (MI), early oral combination lipid-lowering therapy (LLT) is beneficial.

A potential strategy introduces an entirely new type of therapy capable of addressing previously ‘undruggable’ targets within ...

Specialists are debating the best approach in cardiogenic shock after a new analysis of data comparing Impella with ...

Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute event. For those who survive a myocardial infarction, the risk of a ...

Researchers at the University of Mississippi have developed technology to detect heart attacks in real time with a high ...